Trial Profile
An open-label, single-dose study to assess the effect of renal impairment on the pharmacokinetic characteristics, safety, and tolerability of megestrol acetate
Status:
Discontinued
Phase of Trial:
Phase I
Latest Information Update: 26 Sep 2022
Price :
$35
*
At a glance
- Drugs Megestrol (Primary)
- Indications Anorexia; Cachexia; Cancer
- Focus Pharmacokinetics
- Sponsors Endo Pharmaceuticals; Par Pharmaceutical Inc
- 08 Apr 2008 New trial record.